but the potential for exploiting viral enzymes to develop potent and specific antiviral drugs was clearly demonstrated. Acyclovir subsequently became a successful treatment for HSV-1 and HSV-2.

The HSV polymerase is the target of acyclovir, the leading antiviral drug for treating HSV infection, and of foscarnet, a ...

According to a new study, oral and intravenous antiviral drug may be helpful ... The patients received 10 milligrams of the drug acyclovir intravenously every eight hours for 14 days.

Global genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing ...

The patient responded adequately to oral acyclovir therapy without any complications ... as high as 75% before the advent of effective antiviral drugs. Antiviral treatment is very effective ...

Although steroids and antivirals -- alone or in combination ... a double-blind trial examining the efficacy of steroids and acyclovir in the early treatment of BP. Adults presenting during ...

Acyclovir 400–800 mg p.o. b.i.d. Valacyclovir 500 mg p.o. b.i.d. Famciclovir 500 mg p.o. b.i.d. Acyclovir 400 mg p.o. t.i.d. Valacyclovir 1 g p.o. b.i.d ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...